Annual EBITDA:
$690.00M-$868.00M(-55.71%)Summary
- As of today, TEVA annual EBITDA is $690.00 million, with the most recent change of -$868.00 million (-55.71%) on December 31, 2024.
- During the last 3 years, TEVA annual EBITDA has fallen by -$2.19 billion (-76.03%).
- TEVA annual EBITDA is now -87.33% below its all-time high of $5.45 billion, reached on December 31, 2014.
Performance
TEVA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$1.32B+$114.53M(+9.49%)Summary
- As of today, TEVA quarterly EBITDA is $1.32 billion, with the most recent change of +$114.53 million (+9.49%) on September 30, 2025.
- Over the past year, TEVA quarterly EBITDA has increased by +$68.15 million (+5.44%).
- TEVA quarterly EBITDA is now -21.10% below its all-time high of $1.67 billion, reached on June 30, 2017.
Performance
TEVA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$4.62B+$68.15M(+1.50%)Summary
- As of today, TEVA TTM EBITDA is $4.62 billion, with the most recent change of +$68.15 million (+1.50%) on September 30, 2025.
- Over the past year, TEVA TTM EBITDA has dropped by -$209.03 million (-4.33%).
- TEVA TTM EBITDA is now -27.93% below its all-time high of $6.41 billion, reached on September 30, 2015.
Performance
TEVA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TEVA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -55.7% | +5.4% | -4.3% |
| 3Y3 Years | -76.0% | +37.8% | +11.9% |
| 5Y5 Years | -46.0% | +20.9% | +2.5% |
TEVA EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -76.0% | +174.6% | -16.2% | +65.9% | -4.3% | +22.3% |
| 5Y | 5-Year | -76.0% | +135.4% | -16.2% | +65.9% | -4.3% | +22.3% |
| All-Time | All-Time | -87.3% | +104.5% | -21.1% | +302.9% | -27.9% | +936.7% |
TEVA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.32B(+9.5%) | $4.62B(+1.5%) |
| Jun 2025 | - | $1.21B(+30.0%) | $4.55B(+3.0%) |
| Mar 2025 | - | $928.00M(-20.4%) | $4.42B(0.0%) |
| Dec 2024 | $690.00M(-55.7%) | $1.17B(-7.0%) | $4.42B(-8.5%) |
| Sep 2024 | - | $1.25B(+16.8%) | $4.83B(+5.3%) |
| Jun 2024 | - | $1.07B(+15.6%) | $4.59B(+3.0%) |
| Mar 2024 | - | $928.00M(-41.1%) | $4.45B(+3.0%) |
| Dec 2023 | $1.56B(+268.4%) | $1.58B(+55.8%) | $4.32B(+12.8%) |
| Sep 2023 | - | $1.01B(+7.7%) | $3.83B(+1.4%) |
| Jun 2023 | - | $939.23M(+17.9%) | $3.78B(-2.0%) |
| Mar 2023 | - | $796.47M(-26.5%) | $3.86B(-3.6%) |
| Dec 2022 | -$925.00M(-132.1%) | $1.08B(+13.0%) | $4.00B(-3.2%) |
| Sep 2022 | - | $959.00M(-5.7%) | $4.13B(-0.9%) |
| Jun 2022 | - | $1.02B(+8.3%) | $4.17B(-1.7%) |
| Mar 2022 | - | $939.00M(-22.8%) | $4.24B(-3.6%) |
| Dec 2021 | $2.88B(+247.8%) | $1.22B(+22.0%) | $4.40B(+1.7%) |
| Sep 2021 | - | $997.00M(-8.5%) | $4.33B(-2.2%) |
| Jun 2021 | - | $1.09B(-0.6%) | $4.42B(+1.1%) |
| Mar 2021 | - | $1.10B(-3.9%) | $4.37B(-3.8%) |
| Dec 2020 | -$1.95B(-252.3%) | $1.14B(+4.4%) | $4.54B(+0.8%) |
| Sep 2020 | - | $1.09B(+5.1%) | $4.51B(-0.7%) |
| Jun 2020 | - | $1.04B(-18.0%) | $4.54B(-1.4%) |
| Mar 2020 | - | $1.27B(+14.9%) | $4.60B(+3.8%) |
| Dec 2019 | $1.28B(+670.5%) | $1.10B(-1.9%) | $4.44B(+4.6%) |
| Sep 2019 | - | $1.13B(+2.0%) | $4.24B(-0.1%) |
| Jun 2019 | - | $1.10B(+0.1%) | $4.25B(-3.3%) |
| Mar 2019 | - | $1.10B(+21.0%) | $4.39B(-6.4%) |
| Dec 2018 | $166.00M(+101.1%) | $910.77M(-19.5%) | $4.69B(-9.8%) |
| Sep 2018 | - | $1.13B(-9.4%) | $5.21B(-5.4%) |
| Jun 2018 | - | $1.25B(-10.8%) | $5.51B(-7.2%) |
| Mar 2018 | - | $1.40B(-1.6%) | $5.93B(-3.0%) |
| Dec 2017 | -$15.39B(-631.9%) | $1.42B(-0.6%) | $6.11B(-2.8%) |
| Sep 2017 | - | $1.43B(-14.5%) | $6.29B(-0.5%) |
| Jun 2017 | - | $1.67B(+5.7%) | $6.32B(+2.0%) |
| Mar 2017 | - | $1.58B(-0.9%) | $6.20B(+0.3%) |
| Dec 2016 | $2.89B(-26.4%) | $1.60B(+9.1%) | $6.18B(+1.1%) |
| Sep 2016 | - | $1.47B(-5.4%) | $6.11B(-2.6%) |
| Jun 2016 | - | $1.55B(-1.0%) | $6.27B(-1.4%) |
| Mar 2016 | - | $1.56B(+2.3%) | $6.36B(-0.6%) |
| Dec 2015 | $3.93B(-27.8%) | $1.53B(-6.0%) | $6.39B(-0.3%) |
| Sep 2015 | - | $1.63B(-0.8%) | $6.41B(+1.7%) |
| Jun 2015 | - | $1.64B(+2.4%) | $6.30B(+2.9%) |
| Mar 2015 | - | $1.60B(+3.4%) | $6.13B(+2.3%) |
| Dec 2014 | $5.45B(+69.9%) | $1.55B(+2.0%) | $5.99B(+9.7%) |
| Sep 2014 | - | $1.52B(+3.6%) | $5.46B(+0.8%) |
| Jun 2014 | - | $1.46B(-0.1%) | $5.42B(+1.6%) |
| Mar 2014 | - | $1.46B(+43.6%) | $5.33B(+1.5%) |
| Dec 2013 | $3.21B(-17.4%) | $1.02B(-30.8%) | $5.26B(-6.1%) |
| Sep 2013 | - | $1.47B(+7.1%) | $5.60B(+0.9%) |
| Jun 2013 | - | $1.38B(-0.6%) | $5.55B(-0.5%) |
| Mar 2013 | - | $1.39B(+1.8%) | $5.58B(-2.5%) |
| Dec 2012 | $3.88B(-8.9%) | $1.36B(-4.4%) | $5.72B(+8.8%) |
| Sep 2012 | - | $1.42B(+1.1%) | $5.26B(+1.6%) |
| Jun 2012 | - | $1.41B(-7.8%) | $5.17B(+5.5%) |
| Mar 2012 | - | $1.53B(+69.5%) | $4.90B(+7.4%) |
| Dec 2011 | $4.26B(-11.7%) | $900.19M(-32.8%) | $4.56B(-9.2%) |
| Sep 2011 | - | $1.34B(+17.9%) | $5.03B(-2.7%) |
| Jun 2011 | - | $1.14B(-4.4%) | $5.17B(-3.4%) |
| Mar 2011 | - | $1.19B(-13.0%) | $5.35B(+1.5%) |
| Dec 2010 | $4.83B(+45.6%) | $1.36B(-7.8%) | $5.27B(+3.7%) |
| Sep 2010 | - | $1.48B(+12.4%) | $5.08B(+8.2%) |
| Jun 2010 | - | $1.32B(+19.0%) | $4.69B(+4.9%) |
| Mar 2010 | - | $1.11B(-6.0%) | $4.47B(+9.4%) |
| Dec 2009 | $3.31B(+102.3%) | $1.18B(+7.7%) | $4.09B(+40.4%) |
| Sep 2009 | - | $1.09B(-0.3%) | $2.91B(+60.1%) |
| Jun 2009 | - | $1.10B(+51.7%) | $1.82B(+14.5%) |
| Mar 2009 | - | $722.38M(-16.5%) | $1.59B(-50.8%) |
| Dec 2008 | $1.64B(-43.8%) | - | - |
| Jun 2008 | - | $865.29M(+8.2%) | $3.23B(+2.3%) |
| Mar 2008 | - | $799.87M(-0.2%) | $3.15B(+7.4%) |
| Dec 2007 | $2.92B(+15.4%) | $801.43M(+5.5%) | $2.94B(+7.8%) |
| Sep 2007 | - | $759.70M(-4.2%) | $2.73B(-2.4%) |
| Jun 2007 | - | $793.41M(+36.3%) | $2.79B(-0.3%) |
| Mar 2007 | - | $582.07M(-1.3%) | $2.80B(+7.3%) |
| Dec 2006 | $2.53B(+62.5%) | $589.98M(-28.7%) | $2.61B(+6.9%) |
| Sep 2006 | - | $827.44M(+3.3%) | $2.44B(+23.6%) |
| Jun 2006 | - | $800.90M(+104.2%) | $1.98B(+28.2%) |
| Mar 2006 | - | $392.26M(-7.2%) | $1.54B(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $1.55B(+11.6%) | $422.61M(+17.3%) | $1.54B(+1.5%) |
| Sep 2005 | - | $360.28M(-1.6%) | $1.52B(-1.3%) |
| Jun 2005 | - | $365.99M(-7.2%) | $1.54B(+4.7%) |
| Mar 2005 | - | $394.34M(-1.5%) | $1.47B(+13.1%) |
| Dec 2004 | $1.39B(+37.6%) | $400.52M(+5.3%) | $1.30B(+15.4%) |
| Sep 2004 | - | $380.35M(+28.0%) | $1.13B(+19.4%) |
| Jun 2004 | - | $297.10M(+32.5%) | $944.90M(+1.6%) |
| Mar 2004 | - | $224.20M(-1.0%) | $929.70M(+5.1%) |
| Dec 2003 | $1.01B(+63.1%) | $226.50M(+14.9%) | $884.80M(+5.2%) |
| Sep 2003 | - | $197.10M(-30.1%) | $840.90M(+9.9%) |
| Jun 2003 | - | $281.90M(+57.2%) | $765.40M(+28.6%) |
| Mar 2003 | - | $179.30M(-1.8%) | $595.10M(+13.6%) |
| Dec 2002 | $620.90M(+27.9%) | $182.60M(+50.2%) | $524.00M(+15.6%) |
| Sep 2002 | - | $121.60M(+9.0%) | $453.16M(+5.2%) |
| Jun 2002 | - | $111.60M(+3.1%) | $430.56M(+6.1%) |
| Mar 2002 | - | $108.20M(-3.2%) | $405.81M(+7.8%) |
| Dec 2001 | $485.58M(+3.3%) | $111.76M(+12.9%) | $376.51M(-14.6%) |
| Sep 2001 | - | $99.00M(+14.0%) | $440.71M(+5.9%) |
| Jun 2001 | - | $86.85M(+10.1%) | $416.13M(-1.6%) |
| Mar 2001 | - | $78.90M(-55.2%) | $422.74M(+5.7%) |
| Dec 2000 | $470.19M(+40.0%) | $175.95M(+136.4%) | $399.83M(+78.6%) |
| Sep 2000 | - | $74.42M(-20.4%) | $223.88M(+49.8%) |
| Jun 2000 | - | $93.46M(+66.9%) | $149.46M(+166.9%) |
| Mar 2000 | - | $56.00M(+41.1%) | $56.00M(+110.1%) |
| Dec 1999 | $335.89M(+28.0%) | - | - |
| Dec 1998 | $262.48M(+16.2%) | - | - |
| Sep 1998 | - | $39.70M(+68.2%) | -$552.30M(-80.9%) |
| Jun 1998 | - | $23.60M(-33.7%) | -$305.30M(-424.5%) |
| Mar 1998 | - | $35.60M(+105.5%) | -$58.20M(-133.5%) |
| Dec 1997 | $225.80M(+30.5%) | -$651.20M(-327.1%) | $173.80M(-37.5%) |
| Sep 1997 | - | $286.70M(+5.9%) | $278.20M(+22.0%) |
| Jun 1997 | - | $270.70M(+1.2%) | $228.10M(+9.9%) |
| Mar 1997 | - | $267.60M(+148.9%) | $207.60M(+60.6%) |
| Dec 1996 | $173.00M(+26.1%) | -$546.80M(-331.1%) | $129.30M(-57.7%) |
| Sep 1996 | - | $236.60M(-5.4%) | $305.50M(+30.4%) |
| Jun 1996 | - | $250.20M(+32.2%) | $234.20M(+66.3%) |
| Mar 1996 | - | $189.30M(+151.1%) | $140.80M(+35.1%) |
| Dec 1995 | $137.20M(+2.2%) | -$370.60M(-324.2%) | $104.20M(-31.1%) |
| Sep 1995 | - | $165.30M(+5.4%) | $151.20M(+16.8%) |
| Jun 1995 | - | $156.80M(+2.7%) | $129.40M(+8.3%) |
| Mar 1995 | - | $152.70M(+147.2%) | $119.50M(+15.5%) |
| Dec 1994 | $134.30M(+24.8%) | -$323.60M(-325.5%) | $103.50M(-28.3%) |
| Sep 1994 | - | $143.50M(-2.3%) | $144.40M(+12.7%) |
| Jun 1994 | - | $146.90M(+7.5%) | $128.10M(+20.6%) |
| Mar 1994 | - | $136.70M(+148.4%) | $106.20M(+20.8%) |
| Dec 1993 | $107.60M(+47.8%) | -$282.70M(-322.2%) | $87.90M(-41.6%) |
| Sep 1993 | - | $127.20M(+1.8%) | $150.50M(+29.4%) |
| Jun 1993 | - | $125.00M(+5.6%) | $116.30M(+38.0%) |
| Mar 1993 | - | $118.40M(+153.8%) | $84.30M(+43.4%) |
| Dec 1992 | $72.80M(+10.5%) | -$220.10M(-336.7%) | $58.80M(-32.1%) |
| Sep 1992 | - | $93.00M(0.0%) | $86.60M(+19.8%) |
| Jun 1992 | - | $93.00M(+0.1%) | $72.30M(+26.6%) |
| Mar 1992 | - | $92.90M(+148.3%) | $57.10M(+10.9%) |
| Dec 1991 | $65.90M(+24.6%) | -$192.30M(-344.3%) | $51.50M(-45.8%) |
| Sep 1991 | - | $78.70M(+1.2%) | $95.00M(+20.4%) |
| Jun 1991 | - | $77.80M(-10.9%) | $78.90M(+11.6%) |
| Mar 1991 | - | $87.30M(+158.7%) | $70.70M(+44.0%) |
| Dec 1990 | $52.90M(+19.4%) | -$148.80M(-337.7%) | $49.10M(+6.0%) |
| Sep 1990 | - | $62.60M(-10.1%) | $46.30M(-2.5%) |
| Jun 1990 | - | $69.60M(+5.9%) | $47.50M(+1.7%) |
| Mar 1990 | - | $65.70M(+143.3%) | $46.70M(-5.1%) |
| Dec 1989 | $44.30M(+46.2%) | -$151.60M(-337.6%) | $49.20M(-37.4%) |
| Sep 1989 | - | $63.80M(-7.3%) | $78.60M(+28.0%) |
| Jun 1989 | - | $68.80M(+0.9%) | $61.40M(+43.8%) |
| Mar 1989 | - | $68.20M(+155.8%) | $42.70M(+74.3%) |
| Dec 1988 | $30.30M(+24.2%) | -$122.20M(-362.2%) | $24.50M(-83.3%) |
| Sep 1988 | - | $46.60M(-7.0%) | $146.70M(+14.1%) |
| Jun 1988 | - | $50.10M(+0.2%) | $128.60M(+22.6%) |
| Mar 1988 | - | $50.00M(+75.4%) | $104.90M(+2284.1%) |
| Sep 1987 | - | $28.50M(+8.0%) | $4.40M(-59.3%) |
| Jun 1987 | - | $26.40M(+130.9%) | $10.80M(-44.0%) |
| Mar 1987 | $24.40M(+58.4%) | -$85.40M(-344.7%) | $19.30M(-60.0%) |
| Dec 1986 | - | $34.90M(0.0%) | $48.20M(+33.5%) |
| Sep 1986 | - | $34.90M(0.0%) | $36.10M(+50.4%) |
| Jun 1986 | - | $34.90M(+161.8%) | $24.00M(+101.7%) |
| Mar 1986 | $15.40M | -$56.50M(-347.8%) | $11.90M(-82.6%) |
| Dec 1985 | - | $22.80M(0.0%) | $68.40M(+50.0%) |
| Sep 1985 | - | $22.80M(0.0%) | $45.60M(+100.0%) |
| Jun 1985 | - | $22.80M | $22.80M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual EBITDA?
- What is the all-time high annual EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual EBITDA year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly EBITDA year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM EBITDA?
- What is the all-time high TTM EBITDA for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM EBITDA year-on-year change?
What is Teva Pharmaceutical Industries Limited annual EBITDA?
The current annual EBITDA of TEVA is $690.00M
What is the all-time high annual EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual EBITDA is $5.45B
What is Teva Pharmaceutical Industries Limited annual EBITDA year-on-year change?
Over the past year, TEVA annual EBITDA has changed by -$868.00M (-55.71%)
What is Teva Pharmaceutical Industries Limited quarterly EBITDA?
The current quarterly EBITDA of TEVA is $1.32B
What is the all-time high quarterly EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly EBITDA is $1.67B
What is Teva Pharmaceutical Industries Limited quarterly EBITDA year-on-year change?
Over the past year, TEVA quarterly EBITDA has changed by +$68.15M (+5.44%)
What is Teva Pharmaceutical Industries Limited TTM EBITDA?
The current TTM EBITDA of TEVA is $4.62B
What is the all-time high TTM EBITDA for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM EBITDA is $6.41B
What is Teva Pharmaceutical Industries Limited TTM EBITDA year-on-year change?
Over the past year, TEVA TTM EBITDA has changed by -$209.03M (-4.33%)